# Necrotizing Fasciitis

Necrotizing fasciitis is a surgical emergency: recognize disproportionate pain and systemic toxicity, obtain focused laboratory assessment and selective imaging, but do not permit testing to delay operative exploration, broad intravenous antimicrobials, and serial source control.

**Clinical question:** How should physicians rapidly diagnose and manage suspected necrotizing fasciitis without delaying source control?

Updated: 2026-09-15T22:27:41.985733+00:00

## What matters in practice
- Treat a compatible rapidly progressive soft-tissue infection with pain or systemic illness out of proportion to the skin examination as necrotizing fasciitis until operative assessment proves otherwise. [5][24]
- Obtain CRP, CBC, sodium, creatinine, glucose, and hemoglobin if this does not interrupt resuscitation or surgical mobilization; LRINEC is an adjunct, and a low score does not exclude disease. [16][22][23]
- CT, ultrasound, or MRI may help in equivocal cases, but imaging must never delay surgical exploration when clinical suspicion is high. [5][12][14]
- Urgent extensive operative exploration and debridement plus broad-spectrum parenteral antibiotics are the primary treatments; leave the wound open and re-inspect at 24 hours. [5][18]
- After group A streptococcal necrotizing fasciitis is confirmed, use high-dose penicillin plus clindamycin for toxin suppression. [5]

## When suspected necrotizing fasciitis requires immediate operative escalation

Clinical trajectory and systemic toxicity should determine urgency, not the appearance of the overlying skin.

Activate emergency surgical evaluation when a soft-tissue infection progresses rapidly, has severe pain or systemic findings disproportionate to local examination, or develops sharply demarcated lesions, skin sloughing, necrotic eschar, or compartment syndrome. Fascia and subcutaneous fat may be extensively involved while skin and muscle remain relatively spared early, so preserved skin does not provide reassurance. [5][7]

Obtain immediate intravenous access, hemodynamic assessment, and surgical consultation while starting parenteral broad-spectrum antibiotics. Necrotizing fasciitis carries reported mortality of 20% to 50%; group A streptococcal myositis has reported fatality of 80% to 100%, supporting a low threshold for immediate source-control evaluation. [7][8]

For perineal, scrotal, anal, or genital involvement, treat the process as Fournier gangrene and mobilize operative management without awaiting urologic diagnosis. Severe scrotal pain or fever also warrants urgent consideration of torsion, testicular infarction, abscess, and necrotizing infection; urologic consultation is appropriate when Fournier gangrene is suspected. [6][19]
- Escalate immediately for pain or systemic toxicity out of proportion to local findings. [5]
- Treat progression to extremity compartment syndrome as an emergent fasciotomy indication. [5]
- Do not use a trial of outpatient antimicrobials to resolve a high-suspicion presentation. Surgical exploration is the diagnostic and therapeutic priority. [5][14]

*Clinical findings that change the urgency of operative assessment. [5][7]*

| Finding | Interpretation | Next action |
| --- | --- | --- |
| Rapid progression after trivial or unapparent trauma | Compatible with necrotizing infection, including group A streptococcal disease. [7] | Obtain emergency surgical assessment and begin parenteral antibiotics. [5][8] |
| Systemic illness disproportionate to local skin findings | Raises suspicion even when initial cutaneous changes are nonspecific. [5] | Do not delay exploration for confirmatory imaging. [5] |
| Sharply demarcated lesion, sloughing, or necrotic eschar | Represents advanced disease. [5] | Proceed to operative debridement and plan repeat wound inspection. [5] |
| Perineal, genital, or scrotal involvement | Suggests Fournier gangrene, a necrotizing fasciitis phenotype. [19] | Urgently involve surgical services; add urology when indicated by anatomic involvement. [6] |

## How to use laboratories, LRINEC, and imaging without delaying exploration

Testing is useful for risk assessment and operative planning, not for excluding disease in a clinically high-risk patient.

Order CBC with platelet count, creatine phosphokinase, renal indices, and the LRINEC component tests—CRP, hemoglobin, white blood cell count, sodium, creatinine, and glucose—while surgical evaluation is being arranged. Leukocytosis, thrombocytopenia, elevated creatine phosphokinase, and azotemia are common laboratory abnormalities. [5][16]

Interpret LRINEC as a contextual risk tool rather than a rule-out test. A score of 6 or greater is conventionally considered intermediate or high risk and should increase concern, but reported sensitivity ranges from 43% to 80%; infection site, organism, renal function, and peripheral vascular disease can alter performance. A low LRINEC score cannot exclude necrotizing fasciitis. [15][22][23][24]

In an equivocal but stable presentation, contrast-enhanced CT can define gas, deep fascial thickening, multicompartment inflammation, abscess, and the anatomic extent of disease; CT is more sensitive than radiography for necrotizing soft-tissue infection. CT findings of multicompartment inflammation and deep fascial thickening greater than 3 mm combined with LRINEC 7 or greater have been reported to increase diagnostic sensitivity to 96%. [12][15]

Use bedside ultrasound as a rapid adjunct when available. Subcutaneous thickening, air, and fascial fluid comprise the STAFF examination pattern; reported ultrasound performance varies by disease location and extent, so negative ultrasound cannot safely override high clinical suspicion. MRI, CT, bedside testing, or frozen-section biopsy may be considered only when the diagnosis remains equivocal and their use does not postpone definitive exploration. [13][14]
- Collect blood and, when feasible, operative tissue for culture and susceptibility testing; obtain tissue before surgery only if it does not delay debridement. [16]
- If the diagnosis remains uncertain after examination and initial studies, a finger test or frozen-section biopsy can supplement evaluation, but surgical exploration remains the principal investigation. [14][17]
- A negative needle aspiration or incision biopsy does not exclude necrotizing fasciitis. [24]

### Operative and bedside diagnostic findings

When immediate formal exploration is not yet underway in an equivocal high-risk case, the finger test consists of a 2-cm incision to the deep fascia under local anesthesia followed by blunt digital probing. Dishwater pus, lack of bleeding, and minimal resistance to blunt dissection are positive findings that should trigger definitive operative debridement. [14]

*Interpretation of diagnostic tools in suspected necrotizing fasciitis. [5][13][14][15][22]*

| Tool | Actionable finding | Limitation and decision |
| --- | --- | --- |
| LRINEC | Score 6 or greater increases concern; score 7 or greater has been combined with CT features in diagnostic models. [15][17][24] | Low scores do not exclude disease; never use LRINEC to defer surgery in a high-suspicion case. [22][23] |
| Contrast-enhanced CT | Gas, deep fascial thickening, multicompartment inflammation, abscess, or necrotic tissue support NSTI and help map extent. [15] | Useful in equivocal stable patients; do not allow CT to delay exploration. [5][12] |
| Bedside ultrasound | Subcutaneous thickening, air, and fascial fluid support NSTI. [13] | Performance varies by location and extent; a nondiagnostic examination cannot rule out NSTI. [13] |
| Finger test or frozen section | Dishwater pus, absent bleeding, and easy fascial dissection support necrotizing infection. [14] | Use as a complement in equivocal cases, not as a substitute for operative exploration. [14][17] |

## Surgical exploration, debridement, and planned re-exploration

Surgery establishes the diagnosis and removes devitalized tissue.

Proceed to urgent operative exploration when suspicion is high. Surgical exploration is the mainstay of both investigation and treatment, and aggressive debridement is critical for removal of devitalized tissue. Initial incisions should extend beyond visibly involved tissue because external findings can underestimate fascial spread. [5][7][14]

Leave the wound open after initial debridement and re-inspect at 24 hours to assess whether source control was adequate. Repeat debridement should be performed when nonviable tissue persists or infection continues to extend; serial washouts and debridements are frequently required. [5][13]

Obtain deep tissue specimens for Gram stain, culture, susceptibility testing, and histopathologic evaluation when this can be accomplished during operative care. Use Gram stain and culture results to narrow antimicrobial therapy after adequate source control, but do not wait for them before initial broad-spectrum treatment. [5][16][17]
- Plan a postoperative critical-care level of monitoring when shock, vasopressor requirement, respiratory failure, or multiorgan dysfunction is present. [13]
- For extremity disease complicated by compartment syndrome, perform emergent fasciotomy in addition to debridement as indicated. [5]
- Reassess the operative bed rather than relying on improving surface erythema or laboratory values alone. The wound should be directly re-inspected after the first operation. [5]

*Source-control sequence for suspected necrotizing fasciitis. [5][14][16]*

| Phase | Required action | Purpose |
| --- | --- | --- |
| Before incision | Mobilize surgery and start broad-spectrum parenteral antibiotics; obtain cultures if this does not delay surgery. [5][16] | Avoid treatment delay while preserving microbiologic data when feasible. [16] |
| Initial operation | Explore fascia and perform extensive debridement beyond apparent involvement. [5][14] | Establish diagnosis and remove nonviable tissue. [7][14] |
| Postoperative plan | Leave wound open and re-inspect at 24 hours. [5] | Identify inadequate initial source control or ongoing necrosis. [5] |
| Subsequent operations | Repeat washout or debridement when tissue remains nonviable or infection extends. [5][13] | Achieve durable source control. [5] |

## Empiric coverage and pathogen-directed treatment

Begin broad-spectrum intravenous therapy with surgical management, then narrow to operative microbiology.

Start broad-spectrum parenteral antibiotics at the time necrotizing fasciitis is suspected and couple therapy with urgent surgery. Definitive antibiotic selection should be based on intraoperative Gram stain findings and subsequent cultures, but antimicrobial therapy cannot substitute for debridement. [5][8][18]

If group A streptococcus is confirmed, use high-dose penicillin plus clindamycin; clindamycin is used because it interferes with toxin production. Group A streptococcal necrotizing infection may occur after trivial or unapparent trauma and is associated with severe systemic illness. [5][7]

Anticipate different microbiologic patterns from host and wound context. Monomicrobial disease is commonly caused by group A streptococcus, Staphylococcus aureus, or clostridial species. Mixed aerobic gram-negative, anaerobic, and microaerophilic streptococcal infections are described particularly in patients with diabetes or wounds contaminated with bowel contents, supporting broad initial coverage until cultures permit de-escalation. [7][20]
- Obtain operative tissue—not only superficial swabs—when possible for culture, susceptibility testing, and microbiologic correlation. [16][17]
- Reassess antimicrobial selection after Gram stain and culture data return; confirmed group A streptococcal disease specifically calls for penicillin plus clindamycin. [5]
- Do not delay debridement while waiting for antimicrobial response, imaging, or culture results. [5][20]

*Etiologic patterns that guide antimicrobial narrowing after operative sampling. [5][7][20]*

| Pattern | Clinical context | Culture-directed implication |
| --- | --- | --- |
| Group A streptococcal necrotizing fasciitis | May follow trivial trauma and can produce severe systemic illness. [7] | Use high-dose penicillin plus clindamycin after confirmation. [5] |
| Clostridial disease | Clostridial species are recognized monomicrobial causes of necrotizing infection. [7][20] | Continue operative source control; consider hyperbaric oxygen only as a non-delaying postoperative adjunct. [20] |
| Polymicrobial necrotizing infection | Diabetes or bowel-contaminated wounds can be associated with aerobic gram-negative, anaerobic, and microaerophilic streptococcal infection. [7] | Maintain broad initial parenteral coverage and narrow according to operative cultures. [5][16] |

## Monitoring, adjunctive therapy, and common management errors

Adjuncts are secondary to repeated source control and critical-care reassessment.

Monitor serially for hemodynamic deterioration, organ dysfunction, wound progression, and need for repeat surgery. In severe postoperative cases, intensive-care support may include vasopressors and mechanical ventilation; improvement in lactate and white blood cell count can accompany successful serial debridement but does not replace direct wound reassessment. [13]

Hyperbaric oxygen is controversial for nonclostridial necrotizing soft-tissue infection because prospective randomized survival benefit has not been demonstrated. It may be considered as an adjunct, particularly in clostridial disease, only after initial debridement and only if access does not delay surgery or subsequent debridement. [19][20]

Avoid diagnostic anchoring on cellulitis, abscess, erysipelas, or epididymitis when pain, fever, rapid progression, or systemic toxicity is disproportionate. Necrotizing fasciitis is commonly difficult to distinguish from superficial infection early, and delayed escalation is more consequential than a negative or intermediate laboratory score. [5][6][24]
- Do not use hyperbaric oxygen before initial debridement or in a way that delays operative management. [19][20]
- Use standard precautions for gas gangrene; add contact precautions when wound drainage is extensive. [10]
- Do not attribute increased necrotizing fasciitis risk to nonsteroidal anti-inflammatory drugs on the basis of older retrospective reports; prospective studies have not confirmed that association. [5]

*Postoperative decisions and pitfalls in necrotizing fasciitis. [5][10][13][19][20]*

| Issue | Decision | Avoid |
| --- | --- | --- |
| Open operative wound | Re-inspect at 24 hours and repeat debridement for persistent nonviable tissue or extension. [5] | Assuming one operation establishes durable source control. [5][13] |
| Hyperbaric oxygen | Consider only as a postoperative adjunct that does not interrupt surgical care. [19][20] | Transport or treatment that delays initial or repeat debridement. [19][20] |
| Infection control | Use standard precautions; add contact precautions for extensive wound drainage. [10] | Assuming gas gangrene requires routine transmission-based isolation. [10] |
| Clinical improvement | Integrate hemodynamics, organ function, laboratories, and direct wound assessment. [13] | Using laboratory trend alone to decide against re-exploration. [5][13] |

## References
1. Use of Admission Serum Lactate and Sodium Levels to Predict ... — jamanetwork.com — https://jamanetwork.com/journals/jamasurgery/fullarticle/400590
2. Complicated and deep bacterial skin and soft tissue infections — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/ddg.15493
3. Diagnosis of infection in the foot of patients with diabetes: A ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1002/dmrr.3723
4. A systematic review showing the lack of diagnostic criteria and tools ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.17857
5. Clinical Guidance for Type II Necrotizing Fasciitis | Group A Strep | CDC — www.cdc.gov — https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/necrotizing-fasciitis.html
6. Epididymitis - STI Treatment Guidelines - CDC — www.cdc.gov — https://www.cdc.gov/std/treatment-guidelines/epididymitis.htm
7. Streptococcal Toxic-Shock Syndrome: Spectrum of Disease, Pathogenesis, and New Concepts in Treatment - Volume 1, Number 3—July 1995 - Emerging Infectious Diseases journal - CDC — wwwnc.cdc.gov — https://wwwnc.cdc.gov/eid/article/1/3/95-0301_article
8. Worms and Flesh-Eating Bacteria? The Worst Day of Your Life — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(16)30336-5/fulltext
9. [PDF] CDC/NHSN Surveillance Definitions for Specific Types of Infections — www.cdc.gov — https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf
10. Appendix A: Type and Duration of Precautions Recommended for Selected Infections and Conditions | Infection Control | CDC — www.cdc.gov — https://www.cdc.gov/infection-control/hcp/isolation-precautions/appendix-a-type-duration.html
11. [PDF] PDF - CDC — wwwnc.cdc.gov — https://wwwnc.cdc.gov/eid/content/12/3/pdfs/v12-n3.pdf
12. What Is the Accuracy of Physical Examination, Imaging, and the ... — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(18)30560-2/fulltext
13. Diagnosis of Necrotizing Faciitis with Bedside Ultrasound: the STAFF Exam — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC3935782
14. Current Concepts in the Management of Necrotizing Fasciitis — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4286984
15. Wound Imaging - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/n/statpearls/article-150330
16. Diagnostic Key Points and Surgical Management of Necrotizing Fasciitis: A Retrospective Study - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10949409
17. Diagnosing Necrotizing Fasciitis Using Procalcitonin and a Laboratory Risk Indicator: Brief Overview — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC6080743
18. Skin and Soft Tissue Infections - IDSA — www.idsociety.org — https://www.idsociety.org/practice-guideline/skin-and-soft-tissue-infections
19. Fournier Gangrene - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK549821
20. Necrotizing soft-tissue infections - Surgical Treatment - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK6876
21. Necrotizing Fasciitis - CHEST — journal.chestnet.org — https://journal.chestnet.org/article/S0012-3692(15)46306-8/fulltext
22. Consensus on the diagnosis and treatment of adult necrotizing fasciitis (2025 edition) — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC12225674
23. Early diagnosis of necrotizing fasciitis: Imaging techniques and their combined application — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10784425
24. Necrotizing fasciitis - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC2762295

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.